[1] Martínez-Bermejo E, Luque-Ramírez M, Escobar-Morreale HF.Obesity and the polycystic ovary syndrome[J]. Minerva Endocrinol,2007,32(3):129-140. [2] 代玉洁, 阮祥燕. 生活方式干预疗法治疗多囊卵巢综合征[J].中国实用妇科与产科杂志, 2007, 23(5): 394-396. [3] Tuomtleto J.Prevention of type 2 diabetes mellitus by changes in lifestyle among aubjects with impaired glucose tolerance[J]. New Engl J Med,2001,344(18):1343-1350. [4] 王昕,王岩,陈莹.多囊卵巢综合征的远期预后[J].中国实用妇科与产科杂志,2009,25(1):75-80. [5] 林金芳,李昕,苏椿淋.多囊卵巢综合征患者胰岛素抵抗的诊断方法及治疗策略[J].中国实用妇科与产科杂志,2007,23(9):663-667. [6] Rachoń D.Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome[J]. Exp Clin Endocrinol Diabetes, 2012,120(4):205-209. [7] Ibáez L, de Zegher F. Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome[J]. Hum Reprod, 2003,18(1):57-60. [8] Brown J, Farquhar C, Lee O,et al.Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne[J].Cochrane Database Syst Rev, 2009,2:CD000194. [9] 徐蓓,朱桂金.多囊卵巢综合征的高雄激素血症及治疗[J].中国实用妇科与产科杂志,2007,23(9):669-671. [10] Kim JJ, Chae SJ, Choi YM, et al. Atherogenic changes in low-density lipoprotein particle profiles were not observed in non-obese women with polycystic ovary syndrome[J]. Hum Reprod, 2013,28(5):1354-1360. [11] 游凯.多囊卵巢综合征患者的血脂异常及其处理要点[J].中华妇产科杂志,2007,42(10):716-718. [12] 中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35:390-419. [13] Lacey JV Jr, Sherman ME, Rush BB, et al. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia[J].J Clin Oncol,2010,28(5):788-792. [14] 谢幸, 程晓东. 子宫内膜不典型增生及其处理[J]. 中国实用妇科与产科杂志, 2003, 19(8): 458-459. |